EU Exit Negotiations

Helen Goodman Excerpts

Tuesday 17th October 2017 Commons Chamber

[Mr Davis]

Mr Falconer works at the Department for International Trade, of course, but we are in constant communication with him. With respect to the sequencing of decisions on the implementation phase and the ongoing relationship, my hon. Friend is correct in theory, but in practice we need the implementation phase to be decided early for it to be beneficial to a large number of companies. In his response to the statement, the right hon. and learned Member for Holborn and St Pancras (Keir Starmer) pointed out that some companies will have to make decisions at the end of this year or in the first quarter of next year so that they are able to carry out any necessary changes, so we want to get things under way as quickly as possible.

[Helen Goodman (Bishop Auckland) (Lab)]

Further to the question asked by my hon. Friend the Member for Lewisham East (Heidi Alexander), some representatives from the pharmaceutical industry came to see me last Thursday, and they are desperate for some clarification on future trading relations and regulation. If they do not get some certainty, investment is going to be put back or spent in other countries. Nobody thinks that we should give the EU a blank cheque, but can the Secretary of State not see that if arguing about every £5 billion takes so long that we lose more in GDP, it is not worth it?

[Mr Davis]

First, the Under-Secretary of State for Exiting the European Union, my hon. Friend the Member for Worcester (Mr Walker), had a meeting with the industry this morning, and not for the first time. I have met industry representatives a couple of times as well. Secondly, part of the point of the implementation phase is that it gives them an extra two years of decision making, and that is well within their decision cycle. Thirdly, as for giving a blank cheque, that is Labour’s policy.